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Objective: The aim of the study was to evaluate predictors and clinical relevance of heterotopic ossification (HO) in
patients treated for acetabular fractures in a tertiary referral centre.
Patients and methods: The study is a retrospective cohort study with a nested case–control study. All patients
treated with internal fixation of acetabular fractures from January 2004 to October 2013. Ninety patients had
postoperative imaging available at 6 and 12 months postoperatively and received no prophylaxis. Plain radiographs
were used to grade HO. The Hip disability and Osteoarthritis Outcome Score (HOOS) was used to compare
outcomes between patients suffering from HO with patients who did not.
Results: Sixteen patients (17.7%) suffered from HO. According to the Brooker classification, 5 had class I, 4 class II, 3
class III and 4 class IV HO. Traumatic brain injury (TBI) was the only significant risk factor for developing HO (odds
ratio (OR) 8.6, 95% confidence interval (CI) (1.693–43.753), p = 0.014). The HO rate in patients with an anterior
(ilioinguinal) or posterior (Kocher-Langenbeck) surgical approach was 20% and 21% respectively, and the HO rate in
patients with a combined approach was much lower at 11%. Neither fracture type nor gender nor age increased
the risk of HO significantly. The outcome measured by HOOS was not significantly different between patients with
HO and patients in the control group. Patients with HO Brooker class II–IV had slightly lower (effect estimate +4.25,
95% CI (−10.2 to +12.10), p = 0.220) HOOS compared to the majority of the control group.
Conclusion: A very low rate of HO was found compared to the HO rates described in other studies with similar
patient cohorts who received prophylaxis. Based on our findings and the current literature, we do not recommend
giving prophylaxis against HO to patients after internal fixation of acetabular fractures.
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Heterotopic ossification (HO) in patients receiving in-
ternal fixation of acetabular fractures is a potentially dis-
abling complication that occurs in up to 58% of cases
[1,2]. In many centres, indomethacin or low-dose radio-
therapy is administered as prophylaxis to prevent the
development of HO, although these practices are still* Correspondence: dbaschera@bluewin.ch
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unless otherwise stated.controversial. Heterotopic ossification is a process by
which the soft tissue becomes ossified. It occurs when
primitive mesenchymal cells in the surrounding soft
tissue are transformed into osteoblastic cells. Differenti-
ation occurs within 16 h after surgery and peaks at 32 h
[3]. The trigger for HO following major hip procedures
is unknown, but several risk factors have been named.
HO is commonly classified etiologically into neurogenic,
musculoskeletal trauma related and hereditary. It is sig-
nificantly more prevalent in patients who have sustained
severe head traumas and spinal injuries. Lateral surgical
approach, delay in internal fixation, diffuse idiopathical. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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osteoarthritis are other factors that may contribute to
developing HO. A recent retrospective analysis found
prolonged mechanical ventilation as a risk factor for de-
veloping HO [4]. The most common symptom of HO of
the hip is stiffness of the joint with varying degrees of
range of movement loss. Diagnosis after osteosynthesis
is usually done radiographically with an anterior-posterior
(AP) view of the pelvis and/or the hip. HO of the hip is
classified using the Brooker classification grading HO from
1 to 4 according to the size of the bone islands in the soft
tissue and their relative position to the acetabulum and
the greater trochanter [5]. The only treatment option for
established HO is delayed surgical resection when the
heterotopic bone has matured and is encapsuled, which
is approximately 6 months postoperatively [6].
In many centres, postoperative prophylaxis is admin-
istered. The type of medication and the duration of
treatment recommended vary, but the most common
prophylaxis is indomethacin in a 25-mg dose, three
times daily (or slow release 75 mg once daily), for 7–14
days postoperatively, commenced within 24–48 h after
the surgical procedure. While other non-steroidal anti-
inflammatory drugs (NSAIDs) were found to be effective
for the prevention of HO following total hip replacements,
indomethacin remains the only drug with evidence in
preventing HO following acetabular surgery [7]. A recent
study compared the efficacy of indomethacin given for 3
days, 7 days and 6 weeks compared to placebo and found
the best results in patients prescribed indomethacin for 7
days [8]. The worst results were found in patients that re-
ceived indomethacin for 6 weeks. There was no reduction
of symptomatic HO between groups that received indo-
methacin and placebo group [8]. In some centres, external
beam radiation in a single dose of 700 to 800 centigray
(cGy) is administered as prophylaxis for HO 24–72 h
postoperatively. The current literature disputes the effi-
cacy of different types of HO prophylaxis in patients with
acetabular fractures receiving internal fixation.
However, the beneficial effect of HO prophylaxis after
fixation of acetabular fractures has never been ascer-
tained. Both types of prophylaxis have side effects such
as gastric ulcers, renal toxicity and fracture non-union
from NSAIDs and malignancy for irradiation, possible
benefits need to be established [9-15]. The aim of our
study was to assess the rate of HO in a population who
did not receive a prophylaxis. We also aimed to compare
risk factors and functional outcomes of patients receiving
internal fixation for acetabular fractures who developed
HO with patients who did not.
Patients and methods
A retrospective study of patient notes and postoperative
AP pelvic radiographs was performed for all patientsdocumented on the theatre list for internal fixation of
acetabular fractures over a 9-year period from January
2004 to October 2013. The study was approved by the
Royal Perth Hospital review board. All procedures were
performed in a single centre by a single surgical team.
Patients that had follow-up imaging done in another
hospital had to be excluded due to inaccessibility of
necessary x-rays. The main inclusion criteria were the
availability of at least two postoperative radiographs: one
within 12 weeks and 6 months postoperatively during
the typical period of HO development. Medical records
were reviewed for risk factors of developing HO including
head and spinal injuries, male sex, rheumatic diseases,
interval from surgery to internal fixation and surgical ap-
proach. We also reviewed postoperative medications, in
particular NSAIDs. Patients who received prophylaxis or
NSAIDs postoperatively within the first 72 h, which is the
usual period of HO induction, were excluded from the
analysis. Patients who received NSAIDs later than 72 h
postsurgery for more than once-off pain relief were also
excluded.
The Brooker classification was used to grade HO
(Figure 1). The diagnosis was determined by postopera-
tive plain AP view radiographs of the pelvis 1–12 months
after the procedure. The definitive diagnosis was con-
firmed through a second opinion of an independent senior
radiologist.
The patients’ symptoms and functional limitations
were assessed and quantified using the Hip disability
and Osteoarthritis Outcome Score (HOOS) [16,17]. The
HOOS was used to assess the functionality of patients
who developed HO and a randomly (using excel random
function) selected group of a similar size (16 rounded up
to 20) of the patients who did not.
The HOOS is a questionnaire survey intended to be
used to assess the patient’s opinion about their hip and
associated problems and to evaluate symptoms and
functional limitations related to the hip [17]. The out-
come score consists of 40 items assessing five subscales.
The five separate patient-relevant dimensions are pain
(P), symptoms (S), activity limitations daily living (ADL),
function in sport and recreation (SP) and hip-related
quality of life (QOL). Pain (P) includes 10 items with a
total score of 40 points, symptoms (S) includes 5 items
with a total score of 20, activity limitations of daily living
(ADL) includes 17 items with a total score of 68 and
finally function in sport and recreation (SP) and hip-
related quality of life (QOL) both include 4 items with a
total score of 16 each. Patients answered questions with
the following options (0–4): no, mild, moderate, severe
and extreme. To interpret the score, the outcome measure
is transformed in a worst to best scale from 0 to 100, with
100 indicating no symptoms and 0 indicating extreme
symptoms. To calculate the total HOOS score, the
Figure 1 Different grades of heterotopic ossification according to the Brooker classification. I: X-ray of a Brooker class I heterotopic ossification (left hip):
‘islands of bone within soft tissues around the hip’. II: X-ray of a Brooker class II heterotopic ossification (right hip): ‘bone spurs in pelvis or proximal end of
femur leaving at least 1 cm between the opposing bone surfaces’. III: X-ray of a Brooker class III heterotopic ossification (left hip): ‘bone spurs that extend
from the pelvis or the proximal end of femur, which reduce the space between the opposing bone surfaces to less than 1 cm’. IV: X-ray of a Brooker class
IV heterotopic ossification (left hip): ‘radiographic ankylosis of the hip’.
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formula for all dimensions.
100 −
h
ðpatient’s score of the subscale  100Þ
 total score of the subscaleð Þ
i
The subscales can be plotted as a HOOS profile, by
connecting the mean scores for all five dimensions with
a line [17].
Statistical analysis
All available data was analysed using SPSS® (Version
21.0). For the descriptive analysis, categorical variables
like Brooker classification, gender and surgical approach
were compared to each other using Fisher’s exact test.
To compare continuous factors like duration to internal
fixation or age with the dichotomous outcome HO, we
used the Mann–Whitney U test or Kruskal-Wallis test if
there were more than two categories (e.g., surgical ap-
proach). The limit of significance was set to p ≤ 0.05.
Results
Patient selection is displayed in Figure 2. The mean age
of the study population was 34.6 years (14–75). The
male–female ratio was 3:1. The mechanism of injury was
mainly road traffic related with 56 car and 28 motorbike
accidents. The remaining patients sustained injuries infalls (5) or in a skateboard accident (1). The mean inter-
val from injury to operation/internal fixation was 7.47 ±
4.38 days (range 0–19 days). Seven (7.1%) had also sus-
tained concomitant traumatic brain injury (TBI) and 20
(22.2%) had sustained a spine trauma.
Heterotopic ossification was present in 16 patients
(17.7%). According to the Brooker classification, 5 were
classified as Brooker I, 4 as Brooker II, 3 as Brooker III
and 4 as Brooker IV. There were no changes in grading
6 months after the trauma was sustained. The most
common surgical approach was a posterior (Kocher-
Langenbeck) approach (n = 58), followed by combined
posterior-anterior approach (n = 27) and anterior (ilioin-
guinal) approach (n = 5). Similar rates of HO were found
in anterior (20%) and posterior (21%) approaches, while
patients with combined anterior-posterior approach, HO
only developed in 11% of cases. In patients with and
without HO, the fracture types were present in similar
proportions, A2-type fractures (6/37.5% vs. 23/31.1%)
being the most frequent followed by B2-type fractures
(5/31.3% vs. 22/29.7%). None of the fracture types were
associated with a higher risk of HO. Predictors of HO,
their prevalence and unadjusted odds ratios in the groups
with and without HO are displayed in Tables 1 and 2.
Hip disability and Osteoarthritis Outcome Score (HOOS)
Response rate was 12/16 (75%) in the HO group and
13/20 (65%) in the randomly selected control group.
Figure 2 Flow chart displaying patient selection.
Table 2 Unadjusted odds ratios for different predictors of
heterotopic ossification
OR 95% confidence interval p valuea
TBI 8.606 1.693 43.753 0.014*
Spine injury 1.788 0.539 5.933 0.258
Male–female 0.536 0.171 1.680 0.217
Combined approach 1.730 0.592 5.051 0.221
T-type fracture 0.951 0.425 2.132 0.561
aFisher’s exact test (one-sided).
*Significant.
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female ratio and type of fracture in either group as well
as between respondents and non-respondents. The
HOOS in patients with HO and those in the control
group were not statistically different (Table 3). Consider-
ing the grade of Brooker, patients suffering from Brooker
grade II–IV HO had slightly lower HOOS (Figure 3). The
characteristics and variables of the patients with HO are
summarized in Table 4.
Discussion
We found a relatively low HO rate of 17.7% (12.2% HO
class ≥2) in patients with internally fixed acetabularTable 1 Different factors previously reported as risk factors fo
HO (n = 16)
Traumatic brain injury 4 (25%)
Spine injury 5 (31%)
Male–female ratio 10:6 (69%♂; 31%♀)
Interval injury to treatment (days mean ± SD) 9.188 ± 4.35
Age (years mean ± SD) 39.875 ± 17.32
EE effect estimate.
*Statistically significant; ♀ female; ♂male; Fisher exact test (two-sided).fractures who received no prophylaxis. Concomitant TBI
was significantly correlated with a higher risk of HO.
The risk of HO in patients with combined anterior and
posterior approach appeared to be lower than in patients
with either anterior or posterior approach. Another
trend observed was the slightly higher interval to treat-
ment in the group of patients with HO. Surprisingly, the
HOOS was not different between the HO and control
group. Patients with HO graded II–IV according to the
Brooker classification seemed to have slightly lower
HOOS; however, this was not significant. Gender did
not appear to influence occurrence of HO. Concomitant
TBI was the strongest predictor found for HO.
Our overall rate of HO after internal fixation of ace-
tabular fractures was low compared to the rates found in
the literature [1,2]. It was reported to have an incidence
as high as 90% in certain risk groups [18]. Karunakar
et al., who summarized Brooker III-IV and excluded risk
groups (TBI), found HO rates of 15.2%–19.4% (indo-
methacin vs. placebo) [19]. Another RCT compared HO
in fracture patients treated with or without indometh-
acin prophylaxis had much higher HO rates of 47.4%
and 56.8%, respectively [2]. In this study, CT volumetry
was used and detected more clinically irrelevant HO
class I patients. A meta-analysis including 13 articles
classifying HO found an overall incidence of 25.6% [20].
A recent retrospective study in which none of the pa-
tients received prophylaxis found Brooker III–IV HO in
21% of patients with internal fixation of acetabular frac-
tures [21]. Sagi et al. conducted a randomized controlled
trial of patients treated with internal fixation of acetabularr developing heterotopic ossification (HO)
No HO (n = 74) p value 95% CI
3 (4%) p = 0.014*
15 (20.3%) p = 0.337
56:18 (76%♂; 24%♀) p = 0.351
7.095 ± 4.33 p = 0.074; EE = −2 −4 to 0
34.473 ± 13.30 p = 0.281; EE = −2 −13 to 4
Table 3 Hip disability and Osteoarthritis Outcome Score
(HOOS)
Mean Median ±SD Range
HO 85.03 85.9 ±10.52 61–100
Control 86.04 95.5 ±15.33 51–100
p value 0.525 0.220
Estimate +4.25
95% CI −10.2 to +12.10
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group or one of the three groups receiving indomethacin
prophylaxis for the duration of 3 days, 1 week, and 6
weeks, respectively [8]. They reported rates of symptom-
atic HO (Brooker III–IV) in 19% of the placebo group and
in 6%–31% of the three prophylactic groups and found no
statistically significant reduction of symptomatic HO [8].
Patients with acetabular fractures and TBI had a much
higher risk of HO. This has been observed in previous
studies, and the causal correlation has at least partially
been explained [22-25]. Other traditional risk factors like
gender, higher age and T-type fracture reported in sev-
eral studies seemed less meaningful [26]. The present
study shows a lower HO rate among patients with a
more extensive combined anterior and posterior ap-
proach which could mean that this approach might have
been beneficial to these patients with regard to HO. This
may be due to a more thorough debridement and more
anatomical reduction in those patients. Similarly to a
study by Daum et al., a longer surgical delay was also
found in patients who developed HO [27]. Mears et al.
already found that a surgical delay of more than 11 days
resulted in fewer anatomical reductions [28]. Maybe aFigure 3 Hip Osteoarthritis Outcome Score according to the
grade of heterotopic ossification (0 = none; 1–4 HO according to
Brooker classification).poor reduction rate in patients with longer surgical delay
may have lead to a higher rate of HO.
The outcome (HOOS) in this study was not much dif-
ferent in patients with HO. Only patients with class III
or IV HO had slightly lower scores. McLaren already
found that HO grade I (Brooker classification) has no
clinical relevance. He found no association of grade I
HO with decreased range of motion of the hip or any
loss of function. Grade II was associated with a loss of
range of motion of the hip without loss of function
whereas functional impairment was found in grade III
and IV HO [29]. The latter findings were not replicated
in the present study results, and therefore, the clinical
significance of HO for the outcome in acetabular frac-
ture patients seems questionable.
In the light of this, the possible side effects of any
prophylaxis should be considered. In the case of radio-
prophylaxis, one side effect is malignancy. Despite con-
cluding that lifetime risk of radiation-induced cancer or
infertility was insignificant, Oertel et al. found in a com-
plex experimental model that prophylactic irradiation
after fixation of an acetabular fracture in a 30-year-old
patient results in a cumulative increased risk of solid
cancer by 1% at the age of 65 [12]. Gastrointestinal and
renal toxicity are known complications of treatment with
NSAIDs [10,11,13,14]. In one study, compliance to med-
ical prophylaxis was measured by control of indometh-
acin serum level and interviews. It was found that one
third of the patients admittedly withdrew from taking
indomethacin [19]. More than half of them did so be-
cause of side effects (13 compared to 1 in the placebo
group). Two studies demonstrated that indomethacin
prophylaxis significantly increases the risk of non-union
in concomitant long-bone fractures, which are very
common in acetabular fracture patients [9,15].
The strength of our study is the relatively large num-
ber of acetabular fractures reviewed in one centre and
treated by one surgical team. This minimizes the risk of
bias through individual differences or techniques of the
surgical treatment. None of the patients included re-
ceived indomethacin or irradiation prophylaxis. The lim-
itations of our study are that it is non-randomized. Bias
is possible due to the retrospective design and some loss
to follow-up due to missing radiographs. Despite the
relatively large number of patients with internally fixed
acetabular fractures included, the number of patients
with HO was low and therefore limiting the statistical
power of our study. However, a study with the largest
cohort which examined the effect of prophylaxis against
HO in patients with internally fixed acetabular fractures
failed to gain sufficient statistical power [19].
Instead of new research emphasizing on the kind of
prophylaxis needed, randomized controlled studies should
question if there is an effect of prophylaxis at all. Possible
Table 4 Characteristics and variables of patients with heterotopic ossification
Age Sex Mechanism Interval to treatment (days) Surgical approach TBI Spinal trauma AO-OTA classification HOOS Brooker class
42 f MVA 10 Posterior No Spinal injury A3 84.6 4
27 m MVA 6 Posterior No Spinal injury A2 95 1
16 f MBA 9 Anterior No Nil B2 87.5 1
45 m MVA 4 Posterior No Nil A2 x 2
62 m MVA 4 Posterior Yes Spinal injury A2 x 1
22 f MVA 6 Posterior No Nil A1 x 1
27 m MBA 5 Posterior No Nil A1 85.9 2
74 f MVA 19 Posterior No Nil A2 96.9a 1
47 f MVA 7 Combined No Nil B2 73.8 3
42 F MVA 10 Combined No Nil B2 85.9 3
35 m MBA 10 Combined Yes Spinal injury B2 x 2
67 m MVA 12 Posterior No Nil A2 80.6 4
52 m MVA 13 Posterior No Nil B2 88.6 3
35 m MVA 16 Posterior No Nil B1 x 2
21 m MVA 5 Posterior Yes Nil A2 61.3 4
24 m MBA 11 Posterior Yes Spinal injury A1 100 4
MBA motor bike accident, MVA motor vehicle accident, TBI traumatic brain injury.
aPatient had a total hip replacement 1 year after the accident; x = Hip and Osteoarthritis Outcome Score (HOOS) could not be obtained.
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(invasiveness, thoroughness of debridement) could explain
higher HO rates found in earlier studies. The influence of
the time interval from injury to treatment should be
considered, and early fixation without unnecessary delay
should be aimed for. From our results, we cannot recom-
mend giving prophylaxis against HO to patients after
internal fixation of acetabular fractures. The question of
whether prophylaxis has any beneficial effect for patients
considered high risk for developing postoperative HO,
such as patients with TBI, is not yet proven.Conclusion
A low rate of HO was found in this patient cohort that
received no prophylaxis in comparison to HO rates
described in other studies, which included similar
patient groups that received prophylaxis. Traumatic
brain injury was the only confirmed factor that increased
the risk of HO significantly. Longer intervals from injury
to internal fixation were observed in patients with HO.
An important measure to prevent HO might be to avoid
unnecessary delay of internal fixation of the fractures.
Based on our findings and the current literature, giving
patients routine prophylaxis against HO after internal
fixation of acetabular fractures is not recommended.
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